In the current political climate, it is rare to see legislators from both sides of the aisle agree on an...
The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings...
AMAC Action Weekly Advocacy Update: AMAC Members Help Spark Investigation Following a robust nationwide outreach campaign from AMAC Members, the...
July 25, 2024 Washington, D.C. – Following a robust nationwide outreach campaign from AMAC Members, the Federal Trade Commission (FTC)...
The role of middlemen in the high cost of prescription drugs has become a topic of furious discussion and debate...
In his State of the Union address, President Biden doubled down on his commitment to decreasing drug prices by expanding...
Local pharmacies are boarding up nationwide. Nearly 2,200 American pharmacies shut their doors between 2017 and 2020, leaving 20,000 in...
Members of Congress on both sides of the aisle are examining how industry middlemen known as Pharmacy Benefit Managers (PBMs)...
As practicing physicians and medical professionals, we stand at the front lines of patient care, witnessing firsthand the effect of...
A system of kickbacks between drugmakers and drug middlemen is increasing costs for seniors on Medicare, the U.S. Government Accountability...
The 118th Congress is off to a great start in shining a light on the harmful practices of pharmacy benefit managers...
Reduced competition, shortages, and unaffordable options in healthcare are symptoms of middlemen running amok. These middlemen are the healthcare administrators, who rarely...
As the landscape around reproductive rights in the United States is shifting, the middlemen of the drug supply chain, Pharmacy...
Download the AMAC App
"*" indicates required fields
Copyright © 2024 AMAC, Inc. / AMAC Senior Resources Network. All rights reserved.
